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The kidney has several defense mechanisms to avert
nephrocalcinosis by preventing intratubular crystal formation
and adherence. Little is known about the fate of luminally
adhered crystals. In order to study post–crystal adhesion
defense mechanisms we quantified the number and
morphology of crystal-containing tubules in rats at various
time points following ethylene glycol administration as well
as in renal biopsies of patients diagnosed with
nephrocalcinosis of different etiology. In rats,
nephrocalcinosis was completely cleared by epithelial
overgrowth of adherent crystals, which were then
translocated to the interstitium and subsequently
disintegrated. These processes correlated with a low to
moderate infiltration of inflammatory cells. Patients with
nephrocalcinosis due either to acute phosphate
nephropathy, primary hyperoxaluria, preterm birth, or
transplantation also showed epithelial crystal overgrowth
independent of the underlying disorder or the nature of
the crystals. Our study found a quantitative association
between changes in tubular and crystalline morphology
and crystal clearance, demonstrating the presence of an
important and active nephrocalcinosis-clearing mechanism
in both rat and man.
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One of the major functions of the kidney is to remove solute
and waste material from the body. During this process, the
concentrations of calcium (Ca) and its anionic ligands
phosphate (P) and oxalate (Ox) can increase up to the
level of supersaturation, increasing the risk of crystal
formation. Subsequent adherence of intratubular calcium
phosphate (CaP) and/or calcium oxalate (CaOx) crystals to
undifferentiated/regenerating tubular epithelial cells defines
intratubular nephrocalcinosis.1–3 These crystal-bearing
epithelia might compromise proper tubular function as
undifferentiated cells cannot exert the multiple functional
processes of mature, fully polarized epithelial cells. In
addition, intratubular-adhered crystals can engender inflam-
mation and may hinder tubular fluid dynamics.4 However,
the kidney has developed several defense mechanisms acting
at different levels.
At the physiological level, a high concentration of calcium
itself is able to reduce antidiuretic hormone-stimulated water
permeability of the collecting duct through the calcium
sensing receptor, leading to an increased urinary volume and
a reduced risk of supersaturation.5,6 At the physicochemical
level, the urinary supersaturation capacity can be increased
and crystal formation, growth, and aggregation can be
delayed or prevented by micro- and macromolecular urinary
constituents such as citrate, magnesium, and proteins.7–10 At
the level of crystal–cell interactions, normal differentiated
tubular epithelia have no affinity for crystals and crystal
retention can be prevented by coating crystals with urinary
macromolecules.1,2,7,11,12 Altogether, the combined actions of
these mechanisms make the kidney intrinsically resistant to
intratubular nephrocalcinosis. However, what would happen
if these renal defense mechanisms are inadequate or fail and
crystals adhere to the tubular epithelium? Will this necessarily
result in permanent tubular loss and decreased renal function
or does the kidney have an additional survival mechanism?
On the one hand, it is obvious from human pathology and
experimental studies that extensive nephrocalcinosis, as
observed in acute phosphate nephropathy and primary
hyperoxaluria, may lead to renal damage and functional
deterioration.13 On the other hand, the effect of less-extensive
intratubular crystal adhesion on renal function and tubular
morphology is less straightforward. In kidney transplant
patients, Pinheiro et al.14 reported a 12-year allograft survival
rate of 75% in the absence of nephrocalcinosis, whereas in the
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presence of nephrocalcinosis allograft survival decreased to
48%. Although these data suggest an association between
nephrocalcinosis and a decreased allograft survival, it should
be noted that the survival of almost half of the allografts with
nephrocalcinosis is not influenced by crystal deposition. Also,
in several prospective and retrospective studies, in which ex-
preterm neonates with nephrocalcinosis were compared with
birth-weight and postnatal (or gestational) age-matched
controls without nephrocalcinosis, no clear evidence for an
association between neonatal nephrocalcinosis and renal
dysfunction in the long term was found.15–18 Importantly,
these and other preterm follow-up studies described resolu-
tion of nephrocalcinosis (in up to 75% of patients) with age
and discontinuation or adaptation of neonate diuretic
therapy.15–17,19,20 Even so, in patients with obesity-related
jejunoileal bypass-induced enteric hyperoxaluria, where
kidneys progress towards renal insufficiency secondary to
oxalate nephropathy, restoration of gastrointestinal continu-
ity has a stabilizing or partial reversible effect in the
decreasing renal function.21–24
On the basis of the above observations, we hypothesize
that progression of nephrocalcinosis not only depends on the
extent, rate, and duration of intratubular crystal adhesion,
but also is additionally countered by a post-adhesion crystal
clearing mechanism, which might avoid, slow down or even
reverse the progression towards renal insufficiency. In other
words, kidneys in which crystal adhesion exceeds a certain
threshold might deteriorate, whereas below this threshold the
kidney may (continuously) clear the adhered crystal deposits
and secure renal function. To find evidence of such a defense
mechanism, the recovery phase following an established
ethylene glycol (EG)-induced nephrocalcinosis was investi-
gated with respect to crystal clearance and concurrent
changes in tubulointerstitial phenotype. As a clinical
correlate, human biopsy specimens of four different clinical
settings known to be associated with various degrees of
nephrocalcinosis were morphologically evaluated; that is two
disorders with extensive crystal deposition—acute phosphate
nephropathy (CaP) and primary hyperoxaluria (CaOx)—and
two disorders with less prominent nephrocalcinosis—pre-
term infants (CaOx) and kidney transplant patients (CaOx
and CaP).
RESULTS
Urine and serum biochemistry
In the control animals, the median of urinary oxalate
excretion was 0.77 mg/24 h (range: 0.02–1.06) (Figure 1a).
Supplementation of the drinking water with 0.75% EG
induced hyperoxaluria, with an oxalate excretion of 2.57 mg/
24 h (range: 0.29–14.36) during EG administration. Hyper-
oxaluria persisted, at a lower level, until 2 days after stopping
EG administration (1.31 mg/24 h; range: 1.11–4.14). At day 5
after arrest of EG administration oxalate excretion had
dropped to control values. During the study, serum
creatinine (0.40 mg/100 ml; range: 0.10–2.90) levels of EG-
administered animals did not differ significantly from
controls (0.35 mg/100 ml; range: 0.20–0.50, P40.05). Urine
production and water consumption moderately increased
during EG administration and evolved to normal levels when
EG was withdrawn (data not shown).
Crystalluria
Control animals did not show CaOx crystals in their urinary
pellets, however coffin and trapezoidal-shaped triphosphate
crystals were present occasionally. The calcium content in
pellets of centrifuged urine of controls was low (0.16 mg/24 h;
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Figure 1 | Urinary biochemistry and nephrocalcinosis. (a) Urinary oxalate excretion showing the transient effect of EG administration
with hyperoxaluria persisting until day 2 after arrest of EG administration. (b) Urinary pellet calcium shows clear crystalluria during EG
administration only. (c) Renal crystal content during recovery after arrest of EG administration. Quantification of the amount of crystal-
containing tubules/sites on Von Kossa-stained sections shows clearance of nephrocalcinosis. Data are presented as individual values
(diamonds) and median (horizontal bars). Black diamonds represent the animals where phenotypical evaluation (Figure 2) was performed.
Asterisk represents combined individual data of animals killed at days 1, 2, 3, and 4 during EG administration. # represents values
of control animals of each group killed during and after the EG administration period.N represents values of control animals of each group
killed after arrest of EG administration. In the graphs, letters a–d represent Po0.05 versus control (Ctr), þ 2, þ 5, and þ 10, respectively, by
Mann–Whitney U-test.
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range: 0.06–0.57) (Figure 1b). However, during EG admin-
istration the urinary pellets of EG-administered animals
clearly contained CaOx crystals (mainly bipyramidal calcium
oxalate dihydrate) and the median of centrifugeable calcium
excretion increased significantly to 1.18 mg/24 h (range:
0.12–2.28), indicating crystalluria. Within 48 h after arrest
of EG administration CaOx crystals were no longer observed
by microscopy and the amount of centrifugeable calcium
significantly decreased to below control levels.
Renal crystal content
Control rat kidneys showed no von Kossa-positive crystals in
the tubules (Figure 1c). At 2 days after withdrawal of EG
from the drinking water 364 crystal-containing tubules/sites
(range: 2–1326) per section were present, not significantly
increasing to 536 (range: 1–1782) by day 5. By day 10 after
arrest of EG administration the amount of crystal-containing
tubules/sites decreased to 175 (range: 1–490) and further
decreased to 1 (range: 0–4) by day 25 (Figure 1c). For reason
of clarity quantification per renal region (cortex, outer stripe
of outer medulla, inner stripe of outer medulla, and inner
medulla) was not presented separately as it did not add
additional information to the outcome that nephrocalcinosis
was reversible.
Morphology of crystal-containing tubules
In accordance with a previous study,1 the low-dose and
short-term administration of EG, as used in this study, did
not result in overt renal tubular cell necrosis, nor in massive
interstitial cellular infiltration. Evaluation of the morphology
of the crystal–tubular epithelial interaction and the crystal
associated interstitial reaction pattern in cortex, outer stripe
of outer medulla, inner stripe of outer medulla, and inner
medulla revealed five different phenotypical groups: (1)
normal tubules containing intraluminal crystals either lying
free in the lumen or adjacent to the epithelium, (2) tubules
with crystals adhered to flattened regenerating epithelial cells,
either or not positive for proliferating cell nuclear antigen
(PCNA), (3) tubules with crystals overgrown by the tubular
epithelium, (4) interstitial crystals, and (5) granulomas
(Figure 2). The results of the separate renal regions were
combined for reason of clarity, resulting in the evaluation of
564, 533, 420, and 10 crystal-containing tubules/interstitial
sites (out of three or five animals) at days 2 (n¼ 3), 5 (n¼ 3),
10 (n¼ 3), and 25 (n¼ 5) after arrest of EG administration,
respectively. The mean (± s.d.) relative frequencies of the
five phenotypes of the three or five animals at the different
time points after arrest of EG administration are presented in
Figure 2.
Normal crystal-containing tubules and tubules with
adherent crystals were present from day 2 after arrest of EG
administration on with a relative frequency of 12.5±2.0 and
54.5±5.2%, respectively, and the prevalence of both these
phenotypes gradually decreased to zero by day 25 of EG
recovery (Figure 2a and b). The phenotypical group of
overgrown crystals, defined as crystals covered either by
dividing flattened cells (Figure 2d) or by more differentiated,
polarized epithelia (that is cuboidal cells), presenting base-
ment membranes adjacent to the crystals (Figure 2e and f),
were already seen shortly after arrest of EG administration
(day 2) and represented 28.3±4.2% of all evaluated crystal-
containing tubules/sites at that time, increasing to
49.9±6.4% at day 5 and slightly decreasing to 41.4±10.2%
by day 10. At day 25 these overgrown crystals could no longer
be detected. The frequency of sites with interstitial crystals,
including both intact and disrupted/scattered crystal deposits
(Figure 2h, i and j), almost tripled from 4.8±1.1% at day 2 to
13.4±6.8% at day 5 and showed a further 3.5-fold increase to
46.3±14.2% at day 10. The few remaining crystal deposits
present at day 25 after arrest of EG administration either were
present at interstitial sites (85.0±33.5%) or clearly resided in
granulomatous like structures (15.0±33.5%) (Figure 2k).
During the 4-day EG administration period only an
occasional overgrowth structure, but no interstitial crystals
neither granulomas were observed (data not shown). Overall,
no clear intracellular crystals were seen. Also, by visualization
of brush border (remnants) on epithelial cells distinct from
the crystal adhesion site in crystal-containing tubules,
periodic acid Shiff (PAS) staining revealed that EG-induced
intratubular nephrocalcinosis particularly affects proximal
tubules of cortex and the corticomedullary junction. In
addition, a number of distal tubules were affected and some
of them also showed the phenotypic changes observed in the
proximal tubules.
Morphology of crystals
From a morphological point of view adherent or overgrown
crystals in general showed rather large, uniform intact crystal
lattices (Figure 3a and b) whereas crystal deposits in an
interstitial environment either presented smaller crystallites
at their periphery, or sometimes even were completely
scattered and interspersed by cellular material (Figure 3c
and d). The surface of crystals found in the scarce
granulomas had a microcrystalline appearance, clearly
differing from that of the adhered and overgrown crystals.
Inflammation
No massive interstitial cellular infiltration was observed.
However, evaluation of OX-1 (CD45, common leukocyte
antigen) stained sections revealed a time and tubular
phenotype dependent association of leukocytes with crystal-
containing tubules and crystals (Figure 4a). Although no
quantitative data could be obtained for tubules with non-
adhered and adhered crystals on day 10 after arrest of EG
administration due to the low abundance of these particular
phenotypes at that time point, the association of OX-1þ
cells with crystal-containing tubules and crystals increased
with recovery time (day 2oday 5oday 10) and with
progression of the renal crystal clearing process (adhere-
doovergrownointerstitial; Figure 4a). In contrast, ED-1þ
cells (CD68, monocyte/macrophage) were found only
moderately co-localizing with crystal-containing tubules/sites
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(and crystals) and their association additionally decreased
with time (Figure 4b). No neutrophils were found to be
associated with crystal-containing tubules/sites or crystals.
General morphological evaluation of the renal tissue revealed
no edema and only an exceptional enlargement of the
interstitial compartment.
Crystal-containing tubules with normal epithelium
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Tubules with interstitial crystals
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Figure 2 | Frequency of phenotype. Images of serial sections stained with von Kossa (left) and PAS/PCNA (right), respectively. The amount
of (a) normal tubules with crystals and (b) tubules with crystals adherent to regenerating cells decreases during recovery after arrest of EG
administration. Concomitantly the amount of tubules with (c) crystals overgrown by the tubular epithelium and (g) the number of sites with
interstitial crystals increases. (k) By day 25 only a few crystal-containing granulomas are found. (d) Crystals overgrown by young flattened
epithelial cells, which most likely differentiate into (e) the polarized epithelia covering the crystals and presenting basement membrane
deposition (e: PAS/PCNA, insert; f: Jones stain) and restoration of brush border (e: PAS/PCNA, insert). (g) Interstitial crystals either not (h) or
already (i, j) being disintegrated in the subepithelial environment. (l) Cumulative summary of graphs ‘a’ to ‘k’. Concomitant with the
decrease in renal crystals (Figure 1) the frequency of overgrown and interstitial crystals increases, reaching up to almost 90% by day 10. Of
the few crystals left on day 25 only a minority are found in granulomas. Data are presented as mean (±s.d.) relative frequencies of the five
phenotypes of three animals at time points þ 2, þ 5, and þ 10, and five animals at time point þ 25. In the graphs, letters a–c represent
Po0.05 versus time point þ 2, þ 5, and þ 10, respectively, by w2-test.
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Clinical study
As no serial sections were available from the different human
pathologies, a precise morphological score, based on serial
von Kossa and PAS/PCNA-stained sections, could not be
performed. Nevertheless, the single von Kossa/hematoxylin
and eosin-stained sections allowed to identify crystals
overgrown by a new tubular epithelium. In this way, within
the clinical settings of acute phosphate nephropathy, preterm
neonates, and transplant patients, the average frequency of
clear overgrowth structures (relative to the total number of
crystal-containing tubules/sites per biopsy) was assessed for
each disorder (Figure 5). Acute phosphate nephropathy,
preterm infants and transplant patients showed clear
evidence of crystal overgrowth in 24.4±24.3, 11.8±8.9,
and 28.4±34.0% of crystal-containing tubules/sites, respec-
tively. In primary hyperoxaluria quantification could not be
performed as the extent of nephrocalcinosis and renal
damage did not allow proper evaluation of tubular
morphology. Nevertheless, several clear overgrowth struc-
tures could be identified in these biopsy specimens (Figure 5).
DISCUSSION
Intratubular nephrocalcinosis can be defined as the micro-
scopic observation of CaOx or CaP crystals adhered to the
luminal membrane of undifferentiated/regenerating tubular
epithelial cells.1–3 Intratubular nephrocalcinosis is considered
to be the result of failing or overwhelmed defense mechan-
isms acting at the pre-crystal adhesion level. In the present
study, however, the observed changes in frequencies of the
different crystal-associated tubular phenotypes during re-
covery after arrest of EG administration together with the
morphological changes of the crystals, and the concomitant
decrease/disappearance in the number of renal crystal
deposits, allows the quantitative description of a post-crystal
adhesion scenario, also to be found in humans.
After adhesion of the crystals to the regenerating tubular
epithelium or, occasionally, even to denuded basement
membranes in cases of severe tubular injury resulting in cell
loss, the epithelial cells neighboring the adhesion site stretch
and proliferate over the adhered crystals. This reaction is
independent of the nature of the tubular segment, as both
proximal and distal tubules show overgrowth, and of the
nature of the deposits, as CaOx (primary hyperoxaluria), CaP
(acute phosphate nephropathy), cystine (cystine stone
formers25), and 2,8-dihydroxyadenine crystals (as seen in
kidneys of rats with adenine-induced chronic renal failure
used to study vascular calcification;26 data not shown) are
found to be overgrown by the tubular epithelium. This newly
formed monolayer then differentiates into a mature epithe-
lium—with basement membranes adjacent to the crystals
and restoration of brush border microvilli on the opposite
luminal side (in case of proximal tubules)—thereby exclud-
Tubule with adherent crystals Interstitial crystals
Granuloma
Tubule with overgrown crystals
25 microns
25 microns
20 microns 2 microns 1 micron
25 microns
25 microns
Figure 3 | Morphology of crystals. Images of serial sections either stained with the Von Kossa method (outer left images in a, b, c, d, e;
crystals are black) or prepared for SEM (right hand images). (a) Adhered crystals and (b) overgrown crystals show rather large intact crystal
lattices. (c, d) Interstitial crystals either show smaller crystallites at their periphery (c, white arrows) or are completely scattered and
interspersed with cellular material (d), suggesting crystal disintegration. (e) The surface of crystals in granulomatous structures has a
microcrystalline appearance, as shown in the consecutive magnifications.
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ing the crystalline deposit from the tubular lumen and
restoring epithelial integrity of the tubule. During this
overgrowth process the crystals do not seem to undergo
morphological changes, but are merely directed towards the
interstitium together with the epithelial cells of the original
adhesion site. Following this translocation into the inter-
stitium crystal disintegration becomes morphologically
apparent. Crystals are found broken up into smaller crystal-
lites with cellular material interspersing and surrounding the
crystalline remnants, shielding them from the surrounding
tissue.
The biochemical mechanism by which the overgrown
crystals disintegrate and eventually disappear is currently
unclear. It is evident, however, that the adhered crystal
deposits, ab initio, are too large to undergo endocytosis and
subsequent lysosomal degradation. Therefore, following their
overgrowth, an initial extracellular crystal disintegrating
process has to take place. Biologically, this could be attained
(and controlled) by local acidification by polarized proton
secretion and/or release of lysosomal content (protons and
proteases), resulting in a low-pH-induced chemical dissolu-
tion of the mineral phase and proteolysis of the organic
crystal matrix.27 The identity of the cells and pathways
involved therein has not been provided yet. However,
monocytes, macrophages, and multinucleated giant cells
have been identified in the vicinity of interstitial crystals in
EG-administered rats and glyoxylate-injected mice.28–30 In
addition, de Water et al.31 showed in vitro phagocytosis and
dissolution of CaOx crystals by macrophages, whereas
Papadimitriou and Wee32 reported a selective release of
lysosomal enzymes from cell populations containing multi-
nucleated giant cells. In the present rat study no major
inflammatory reaction was observed. Nevertheless, leukocytes
(OX-1) were found associated with crystal-containing
tubules/sites and crystals and their appearance increased
with time and with the progressive changes of the tubular
phenotype during the extrusion of adhered crystals from the
tubular lumen to the interstitium. Monocytes and macro-
phages (ED-1) were only moderately and transiently found
associated with crystal-containing tubules/sites, with only a
minority of them actually located adjacent to crystal deposits.
Although monocytes/macrophages are functionally capable
of clearing crystals, their limited association suggests either a
transient or minor involvement in renal crystal clearance.
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Figure 4 | Inflammation. Relative percentage of the different crystal containing tubular phenotypes associated with (a) OX-1þ (CD45,
common leukocyte antigen) and (b) ED-1þ (CD68, monocyte/macrophage marker) cells at the different time points after arrest of EG
administration. Whereas the association of OX-1þ cells with crystal-containing tubules/sites and crystals increases with recovery time, the
association with ED-1þ cells is moderate and transient during renal crystal clearance.
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Also, no morphologically apparent neutrophils could be
identified in the vicinity of crystal deposits. Whether, in
general, leukocyte infiltration is merely due to a local crystal-
induced inflammation or whether they are actively recruited
to participate in crystal clearance cannot be deduced from the
current data, nor can the involvement of lymphocytes, other
interstitial cells or the epithelial cells covering the crystals be
excluded.
The importance of the proposed crystal handling
mechanism is corroborated by the following observations.
First, the striking decrease in the number of renal crystals in
the rat study parallels the relative increase of definite
morphological changes of crystal-containing tubules; that is
crystal overgrowth and apparent translocation jointly reach
up to 87% of crystal deposits by day 10 after arrest of EG
administration. Second, alternative clearing mechanisms
quantitatively seem to be less important. For example, the
clearance of nephrocalcinosis might be explained by detach-
ment of crystals from the regenerating/undifferentiated
tubular epithelium, once it has regained its normal
noncrystal-binding phenotype. Such a crystal clearance
mechanism, however, is unlikely to be of great importance
as the number of crystal-containing tubules between days 2
and 5 after arrest of EG administration does not change
significantly, whereas the relative frequency of regenerating
crystal-bearing epithelia decreases and that of overgrown and
interstitial crystals increases. In addition, hyperoxaluria is no
longer present at day 5, making it improbable that the loss of
crystals by crystal detachment is compensated by the
adhesion of newly formed passing crystals. Third, only a
minority of crystal deposits (o0.5% of the original amount
at day 2 after arrest of EG administration) is found to end up
in granulomas, suggesting that the vast majority of crystals
must already have been cleared through a faster alternative
mechanism. Moreover, as observed with scanning electron
microscopy, the different (¼microcrystalline) morphology
of granuloma-embedded crystals suggests that handling of
crystals by granulomas might be of a different nature. Fourth,
as the low-dose and short-term administration of EG, in
accordance with a previous study,1 did not result in acute
renal failure, nor in overt epithelial necrosis nor massive
interstitial cellular infiltration, the vast majority of the large
amount of interstitial crystals is unlikely to be the result of
dystrophic calcification.
In humans, tubular epithelial overgrowth was observed, to
various extents, in all four pathologies under study (acute
phosphate nephropathy, primary hyperoxaluria, transplants
patients, and preterm infants), corroborating the idea that
the human kidney is able to actively counter progression of
nephrocalcinosis and suggesting that this type of renal crystal
handling is a common reaction of the tubular epithelium
towards adhered crystals, unrelated to the underlying disease
and composition of the crystals. This does not exclude the
possibility, however, that the underlying disorder or a
particular treatment could influence the kidney’s potency to
clear crystals. This phenomenon might be occurring in
transplant patients, whose allografts continuously are being
stressed by immunosuppressants and for whom it is known
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hyperoxaluria
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APN Transplants Preterm inf. Prim. hyperoxal.
No data
16
16
16
16 7
8
8
8
6
12
20
10 2
3
3
3
24.4 ± 24.3 28.4 ± 34.0 11.8 ± 8.9
Figure 5 | Frequency and examples of clear overgrowth structures in human kidney biopsies with nephrocalcinosis of different
etiology. Owing to the extent of nephrocalcinosis and renal damage in the biopsies of primary hyperoxaluria no quantitative
morphological data could be obtained.
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that the prevalence of nephrocalcinosis increases with time
after transplantation.33,34 Therefore, it is possible that the
individual outcome of the balance between crystal adhesion
and crystal clearance not only depends on the extent,
duration and rate of crystal adhesion, but also on a ‘renal
(epithelial) health threshold’ above which initiation and
accomplishment of the crystal clearing process is ensured. In
addition, two considerations have to be made. Whereas in
rats the recovery phase was investigated at definite time
points in the absence of a continuous hyperoxaluric/crystal-
luric challenge, human samples were studied in a cross-
sectional manner without information on the extent, rate or
duration of crystal formation/deposition at the moment of
biopsy. Second, it is important to carefully consider whether
interstitial crystal deposits, as observed in intestinal bypass
surgery23 for example, are deposited de novo or are the result
of translocation after epithelial overgrowth. In view of this it
is important to mention that Evan et al. recently described
intraluminal and interstitial crystal deposits (Randall’s
plaques) in stone forming patients due to primary hyperpar-
athyroidism.35 Whether this and our observations can be
linked mechanistically or merely are independent parallel
processes remains to be determined.
In conclusion, our quantitative temporal morphological
evaluation of the fate of intratubular adhered crystals
indicates the presence of an active crystal clearing mechanism
in rat and man, involving epithelial crystal overgrowth, and
interstitial disintegration. This mechanism seems to act
independently of the underlying disorder or the nature of
the crystals. Although epithelial overgrowth of crystals has
been observed earlier,29,36 the present paper, for the first time,
describes a clear quantified association in time between
changes in tubular and crystal morphology on the one hand
and disappearance of crystals on the other. In addition,
evidence is presented corroborating the quantitative impor-
tance of this renal defense mechanism in rat and man.
MATERIALS AND METHODS
Experimental design
A total of 56 male Wistar rats (250–300 g; Iffa Credo, Brussels,
Belgium) were divided into eight groups (n¼ 7 each). Within each
group one (control) animal received normal drinking water, whereas
six received drinking water supplemented with EG (0.75% vol/vol)
during 4 days. For determination of oxaluria, crystalluria, and serum
creatinine during EG administration four groups were killed,
respectively, at days 1, 2, 3, and 4 during the 4-day EG
administration period. After arrest of the 4-day EG administration
period the remaining four groups received normal drinking water
and were killed, respectively, at days 2, 5, 10, and 25 of recovery for
determination of oxaluria, crystalluria, serum creatinine, and
evaluation of nephrocalcinosis and renal morphology. All animals
had free access to standard chow and drinking solution. At 24 h
before killing, animals were housed individually in metabolic cages
to collect 24-h urine samples and to monitor fluid intake. After
sedation (Nembutal) of the rats, a blood sample was taken and
kidneys were excised and decapsulated. Sagittal slices of renal tissue
were immediately fixed in either methacarn (60% methanol, 30%
chloroform, 10% acetic acid) or Dubosq-Brasil fixative (47%
ethanol, 11.7% H2O, 23.5% formaldehyde, 17.6% acetic acid, and
4 mM picric acid) for 4 h, rinsed with 70% ethanol and embedded in
low –melting point paraffin (52 1C; Kendall, Mansfield, MA, USA).
Urine and serum samples were frozen at 20 1C until biochemical
analysis. The experiments were approved by the Ethical Committee
for Animal Experiments of the University of Antwerp.
Urine and serum biochemistry
For the determination of the urinary oxalate 5 ml urine samples
were acidified with 100ml hydrochloric acid (1 M) after which oxalate
was determined by a quantitative enzymatic colorimetric assay
(Sigma Diagnostics, Deisenhofen, Germany). The concentrations of
creatinine in serum were analyzed on a routine autoanalyzer system
(Vitros 750 XRC).
Crystalluria
For the determination of the amount of urinary crystals 3 ml of
urine was centrifuged (10 min, 2500 r.p.m.). The urinary pellet was
resuspended in 500 ml tris saline buffer and acidified with 100 ml of
12% HCl, thereby dissolving precipitated crystals. The calcium
content in this solution was determined by flame atomic absorption
spectrometry (PerkinElmer, Norwalk, CT, USA) and is considered a
measure of crystalluria. In addition, crystalluria was evaluated by
visualization of urinary sediments of a 1 ml centrifuged urine sample
(10 min, 2500 r.p.m.) by optical light microscopy ( 100).
Renal crystal content
Renal calcium deposits were visualized by von Kossa staining.
Deparaffinized Dubosq-Brasil-fixed 4-mm tissue sections were
incubated in 5% silver nitrate for 45 min. Slides were rinsed in
water incubated in 1% pyrogallic acid for 3 min, rinsed with water,
fixed in 5% sodium thiosulfate for 1 min, and counterstained with
hematoxylin and eosin. In each sagittal kidney section (n¼ 1 per
rat), the renal crystal content was quantified by counting the
number of tubules/interstitial sites presenting black-stained crystals
in cortex, outer stripe of outer medulla, inner stripe of outer
medulla, and inner medulla.
Morphology of crystal-containing tubules
Two serial methacarn-fixed tissue sections (4mm) of representative
animals (with a sufficient amount of renal crystals) of each group
(n¼ 3 for days þ 2, þ 5, and þ 10; n¼ 5 for day þ 25) were
stained with von Kossa and PAS/PCNA, respectively. Briefly, in PAS/
PCNA staining, tissue sections were blocked with normal horse
serum and incubated with primary label (mouse anti-human PCNA;
Dako, Carpinteria, CA, USA). Sections were subsequently incubated
with secondary label, biotinylated horse anti-mouse antibody
(Vector, Burlingame, CA, USA). Finally, avidin–biotin peroxidase
complex (Vector) and diaminobenzidine were used to detect PCNA.
No staining was observed when primary labels were omitted.
Subsequently sections were PAS-stained for morphological evalua-
tion. Nuclei were counterstained with methyl green.
The morphology of 100 (cortex), 50 (outer stripe of outer
medulla), 25 (inner stripe of outer medulla), and 25 (inner medulla)
crystal-containing tubules/sites per animal identified on the von
Kossa-stained section, was evaluated on the serial PAS/PCNA-
stained section. In this way the morphology of crystal-containing
tubules could be evaluated and quantified specifically, whereas the
inevitable loss of crystals during PAS/PCNA staining was surpassed.
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Results are represented as the mean (±s.d.) frequency of a certain
phenotype relative to the total number of crystal-containing tubules/
sites per time point.
Morphology of crystals
Two serial methacarn-fixed tissue sections (4mm) of animals (n¼ 1
each) killed at day 3 during and at days 10 and 25 after the 4-day EG
administration period were stained with von Kossa and prepared for
scanning electron microscopy, respectively. Several crystal-contain-
ing tubules/sites with different morphology were selected on the von
Kossa-stained sections and crystal morphology was evaluated on the
serial section by SEM.
Inflammation
Two series of three serial methacarn-fixed sections (4 mm) of animals
(n¼ 1 each) killed at days 2, 5, and 10 after arrest of EG
administration were stained with von Kossa, PAS/PCNA, and either
OX-1 (CD45, leukocyte common antigen) or ED-1 (CD68,
monocyte/macrophage marker), respectively. Briefly, for OX-1 or
ED-1 staining, tissue sections were blocked with normal horse
serum and incubated with primary label (mouse anti-rat leukocyte
common antigen (OX-1) or mouse anti-rat ED-1 (Pharmingen, San
Diego, CA, USA)). Sections were subsequently incubated with
secondary label, biotinylated horse anti-mouse antibody (Vector).
Finally, avidin–biotin peroxidase complex (Vector) and diamino-
benzidine or aminoethylcarbazole were used to detect OX-1 or ED-1,
respectively. No staining was observed when primary labels were
omitted. Nuclei were counterstained with methyl green.
A total of 20 crystal-containing tubules/sites of a particular
phenotype, as identified on the von Kossa- and PAS/PCNA-stained
sections, were scored according to their association with interstitial
OX-1 and ED-1-positive cells. Three types of association were included:
(1) no OX-1þ and/or ED-1þ cells adjacent to crystal-containing
tubule/site, (2) OX-1þ and/or ED-1þ cells adjacent to crystal-
containing tubule, and (3) OX-1þ and/or ED-1þ cells adjacent to
the crystals. Results are presented as the frequency of a particular type
of association relative to the total number of scored crystal-containing
tubules/sites of a particular phenotype per time point.
Clinical study
Tissue sections of formalin fixated renal biopsies from patients with
acute phosphate nephropathy (n¼ 16 patients, 1 biopsy per patient,
1 section available per biopsy), primary hyperoxaluria (n¼ 2, 3
biopsies, 1 section available per biopsy), transplants patients (n¼ 10,
2 biopsies each, 1 section available per biopsy), and preterm infants
(n¼ 8, 1 biopsy each, 1 section available per biopsy) were stained
with the von Kossa method in order to visualize calcium deposits
and quantify/evaluate the number and morphology of crystal-
containing tubules/sites.
Statistics
Data are either presented as mean±standard deviation, as
individual values and as median (þ range). For serum creatinine,
oxaluria, crystalluria, and the amount of crystal-containing tubules
comparisons between the study groups were assessed using a
Kruskal–Wallis test, followed by a Mann–Whitney U-test in
combination with Bonferroni correction when more than two
groups were compared. A value of Po0.05 was considered
significant. Comparison of the frequencies of the different
phenotypes between the different time points after arrest of EG
administration was assessed by the w2-test in combination with
Bonferroni correction when more than two groups were compared.
Statistics were performed with SPSS 14.0 for Windows software.
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